Quart Development S.A. (WSE:QRT)

Oncternal Therapeutics Revenue

Quart Development had revenue of 4.00M PLN in the quarter ending March 31, 2025, a decrease of -30.65%. This brings the company's revenue in the last twelve months to 21.89M, up 37.13% year-over-year. In the year 2024, Quart Development had annual revenue of 23.66M with 119.55% growth.

• Revenue (ttm): 21.89M
• Revenue Growth: +37.13%
• P/S Ratio: 2.23
• Revenue / Employee: 3.13M
• Employees: 5
• Market Cap: 48.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	23.66M	12.88M	119.55%
Dec 31, 2023	10.77M	7.17M	198.82%
Dec 31, 2022	3.61M	-9.80M	-73.10%
Dec 31, 2021	13.40M	-13.06M	-49.36%
Dec 31, 2020	26.47M	20.55M	347.26%